Trade Summary

4 days ago, Mokari Atabak, serving as Chief Financial Officer at CORCEPT THERAPEUTICS INC (CORT), sold 40,000 shares at $70.00 per share, for a total transaction value of $2,800,004.00. Following this transaction, Mokari Atabak now holds 15,257 shares of CORT.

This sale represents a 72.39% decrease in Mokari Atabak's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 1, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 7:20 PM ET, 2 days after the trade was made.

CORCEPT THERAPEUTICS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.